Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Effects of phytoestrogens on bone turnover in postmenopausal women with a history of breast cancer.

Nikander E, Metsä-Heikkilä M, Ylikorkala O, Tiitinen A.

J Clin Endocrinol Metab. 2004 Mar;89(3):1207-12.

PMID:
15001611
2.

Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment.

Garnero P, Shih WJ, Gineyts E, Karpf DB, Delmas PD.

J Clin Endocrinol Metab. 1994 Dec;79(6):1693-700.

PMID:
7989477
3.

Evidence of a lack of effect of a phytoestrogen regimen on the levels of C-reactive protein, E-selectin, and nitrate in postmenopausal women.

Nikander E, Metsä-Heikkilä M, Tiitinen A, Ylikorkala O.

J Clin Endocrinol Metab. 2003 Nov;88(11):5180-5.

PMID:
14602747
4.

Comparison of markers for bone formation and resorption in premenopausal and postmenopausal subjects, and osteoporosis patients.

Kushida K, Takahashi M, Kawana K, Inoue T.

J Clin Endocrinol Metab. 1995 Aug;80(8):2447-50.

PMID:
7629240
5.

A randomized placebo-controlled crossover trial with phytoestrogens in treatment of menopause in breast cancer patients.

Nikander E, Kilkkinen A, Metsä-Heikkilä M, Adlercreutz H, Pietinen P, Tiitinen A, Ylikorkala O.

Obstet Gynecol. 2003 Jun;101(6):1213-20.

PMID:
12798527
6.

Effects of risedronate 5 mg/d on bone mineral density and bone turnover markers in late-postmenopausal women with osteopenia: a multinational, 24-month, randomized, double-blind, placebo-controlled, parallel-group, phase III trial.

Välimäki MJ, Farrerons-Minguella J, Halse J, Kröger H, Maroni M, Mulder H, Muñoz-Torres M, Sääf M, Snorre Øfjord E.

Clin Ther. 2007 Sep;29(9):1937-49.

PMID:
18035193
7.

Effects of tamoxifen and toremifene on urinary excretion of pyridinoline and deoxypyridinoline and bone density in postmenopausal patients with breast cancer.

Marttunen MB, Hietanen P, Titinen A, Roth HJ, Viinikka L, Ylikorkala O.

Calcif Tissue Int. 1999 Nov;65(5):365-8.

PMID:
10541761
8.

Prevention of osteoporosis and uterine effects in postmenopausal women taking raloxifene for 5 years.

Jolly EE, Bjarnason NH, Neven P, Plouffe L Jr, Johnston CC Jr, Watts SD, Arnaud CD, Mason TM, Crans G, Akers R, Draper MW.

Menopause. 2003 Jul-Aug;10(4):337-44.

PMID:
12851517
9.
10.

Changes in bone turnover markers after calcium-enriched milk supplementation in healthy postmenopausal women: a randomized, double-blind, prospective clinical trial.

Palacios S, Castelo-Branco C, Cifuentes I, von Helde S, Baró L, Tapia-Ruano C, Menéndez C, Rueda C.

Menopause. 2005 Jan-Feb;12(1):63-8.

PMID:
15668602
11.

Effect of low-dose alendronate treatment on bone mineral density and bone turnover markers in Chinese postmenopausal women with osteopenia and osteoporosis.

Li M, Zhang ZL, Liao EY, Chen DC, Liu J, Tao TZ, Wu W, Xia WB, Lu YJ, Sheng ZF, Lu CY, Meng GL, Xu L, Zhang WJ, Hu YY, Xu L.

Menopause. 2013 Jan;20(1):72-8. doi: 10.1097/gme.0b013e31825fe2e8.

PMID:
22968256
12.

Serum collagen crosslinks as markers of bone turn-over during GH replacement therapy in growth hormone deficient adults.

Rodríguez-Arnao J, James I, Jabbar A, Trainer PJ, Perrett D, Besser GM, Ross RJ.

Clin Endocrinol (Oxf). 1998 Apr;48(4):455-62.

PMID:
9640412
13.

Effects of dietary phytoestrogens in postmenopausal women.

Dalais FS, Rice GE, Wahlqvist ML, Grehan M, Murkies AL, Medley G, Ayton R, Strauss BJ.

Climacteric. 1998 Jun;1(2):124-9.

PMID:
11907915
14.

Effects of low-dose prednisone on bone metabolism.

Ton FN, Gunawardene SC, Lee H, Neer RM.

J Bone Miner Res. 2005 Mar;20(3):464-70. Epub 2004 Nov 29.

15.

Is skeletal responsiveness to thyroid hormone altered in primary osteoporosis or following estrogen replacement therapy?

Langdahl BL, Loft AG, Møller N, Weeke J, Eriksen EF, Mosekilde L, Charles P.

J Bone Miner Res. 1997 Jan;12(1):78-88.

16.

Early changes in biochemical markers of bone formation predict BMD response to teriparatide in postmenopausal women with osteoporosis.

Chen P, Satterwhite JH, Licata AA, Lewiecki EM, Sipos AA, Misurski DM, Wagman RB.

J Bone Miner Res. 2005 Jun;20(6):962-70. Epub 2005 Jan 18.

17.

Estrogen-dependent increase in bone turnover and bone loss in postmenopausal women with breast cancer treated with anastrozole. Prevention with bisphosphonates.

Confavreux CB, Fontana A, Guastalla JP, Munoz F, Brun J, Delmas PD.

Bone. 2007 Sep;41(3):346-52. Epub 2007 Jun 16.

PMID:
17618847
18.

Effects of intranasal 17beta-estradiol on bone turnover and serum insulin-like growth factor I in postmenopausal women.

Garnero P, Tsouderos Y, Marton I, Pelissier C, Varin C, Delmas PD.

J Clin Endocrinol Metab. 1999 Jul;84(7):2390-7.

PMID:
10404809
19.
20.

Supplemental Content

Support Center